270 related articles for article (PubMed ID: 33538931)
1. Evaluation of vitrectomy combined preoperative intravitreal ranibizumab and postoperative intravitreal triamcinolone acetonide for proliferative diabetic retinopathy.
Hu L; Chen Q; Du Z; Wang W; Zhao G
Int Ophthalmol; 2021 May; 41(5):1635-1642. PubMed ID: 33538931
[TBL] [Abstract][Full Text] [Related]
2. Effect of intravitreal ranibizumab pretreatment on vitrectomy in young patients with proliferative diabetic retinopathy.
Chen HJ; Wang CG; Dou HL; Feng XF; Xu YM; Ma ZZ
Ann Palliat Med; 2020 Jan; 9(1):82-89. PubMed ID: 32005066
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal triamcinolone acetonide as an additional tool in pars plana vitrectomy for proliferative diabetic retinopathy.
Jonas JB; Söfker A; Degenring R
Eur J Ophthalmol; 2003 Jun; 13(5):468-73. PubMed ID: 12841570
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcomes of administration of intravitreal triamcinolone acetonide after posterior vitreous detachment during pars plana vitrectomy for proliferative diabetic retinopathy.
Liao M; Huang Y; Wang J; Meng X; Liu Y; Yu J; Yan H
Br J Ophthalmol; 2023 Apr; 107(4):560-564. PubMed ID: 34844917
[TBL] [Abstract][Full Text] [Related]
5. Prospective Comparison of Surgery Outcome Between Preoperative and Intraoperative Intravitreal Injection of Ranibizumab for Vitrectomy in Proliferative Diabetic Retinopathy Patients.
Li S; Tang J; Han X; Wang Z; Zhang L; Zhao M; Qu J
Ophthalmol Ther; 2022 Oct; 11(5):1833-1845. PubMed ID: 35904708
[TBL] [Abstract][Full Text] [Related]
6. The efficacy and safety of intravitreal injection of Ranibizumab as pre-treatment for vitrectomy in proliferative diabetic retinopathy with vitreous hemorrhage.
Li S; Yang Y; Zou J; Zeng J; Ding C
BMC Ophthalmol; 2022 Feb; 22(1):63. PubMed ID: 35139812
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and Safety of Intravitreal Conbercept, Ranibizumab, and Triamcinolone on 23-Gauge Vitrectomy for Patients with Proliferative Diabetic Retinopathy.
Cui J; Chen H; Lu H; Dong F; Wei D; Jiao Y; Charles S; Gu W; Wang L
J Ophthalmol; 2018; 2018():4927259. PubMed ID: 30046459
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal injection of bevacizumab and triamcinolone acetonide at the end of vitrectomy for diabetic vitreous hemorrhage: a comparative study.
Park DH; Shin JP; Kim SY
Graefes Arch Clin Exp Ophthalmol; 2010 May; 248(5):641-50. PubMed ID: 20012643
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Intravitreal Ranibizumab on the Surgical Outcome for Diabetic Retinopathy With Tractional Retinal Detachment.
Dong F; Yu C; Ding H; Shen L; Lou D
Medicine (Baltimore); 2016 Feb; 95(8):e2731. PubMed ID: 26937902
[TBL] [Abstract][Full Text] [Related]
10. Effect of intravitreal triamcinolone acetonide injection at the end of vitrectomy for vitreous haemorrhage related to proliferative diabetic retinopathy.
Takamura Y; Shimura M; Katome T; Someya H; Sugimoto M; Hirano T; Sakamoto T; Gozawa M; Matsumura T; Inatani M;
Br J Ophthalmol; 2018 Oct; 102(10):1351-1357. PubMed ID: 29343528
[TBL] [Abstract][Full Text] [Related]
11. Intravitreal Conbercept Injection as an Adjuvant in Vitrectomy with Silicone Oil Infusion for Severe Proliferative Diabetic Retinopathy.
Gao S; Lin Z; Chen Y; Xu J; Zhang Q; Chen J; Shen X
J Ocul Pharmacol Ther; 2020 Jun; 36(5):304-310. PubMed ID: 32186940
[No Abstract] [Full Text] [Related]
12. Intravitreal ranibizumab versus vitrectomy for recurrent vitreous haemorrhage after pars plana vitrectomy for proliferative diabetic retinopathy: a prospective study.
Chatziralli I; Dimitriou E; Theodossiadis G; Bourouki E; Bagli E; Kitsos G; Theodossiadis P
Int Ophthalmol; 2020 Apr; 40(4):841-847. PubMed ID: 31788713
[TBL] [Abstract][Full Text] [Related]
13. Erosive Retinopathy and Retinal Detachment From Depot Intravitreal Triamcinolone Acetonide Injection at the End of Pars Plana Vitrectomy.
Sisk RA; Patel YP; Foster RE; Petersen MR
Ophthalmic Surg Lasers Imaging Retina; 2019 Oct; 50(10):613-619. PubMed ID: 31671193
[TBL] [Abstract][Full Text] [Related]
14. Efficacy comparison of intravitreal injections of conbercept and ranibizumab for severe proliferative diabetic retinopathy.
Lu Q; Lu L; Chen B; Chen W; Lu P
Can J Ophthalmol; 2019 Jun; 54(3):291-296. PubMed ID: 31109466
[TBL] [Abstract][Full Text] [Related]
15. A Systematic Review and Meta-Analysis of Clinical Outcomes of Small Gauge Vitrectomy with or without Intravitreal Anti-Vascular Endothelial Growth Factor Agents Pretreatment for Proliferative Diabetic Retinopathy.
Pei M; Zhao X; Wan G
Ophthalmic Res; 2023; 66(1):777-790. PubMed ID: 36972566
[TBL] [Abstract][Full Text] [Related]
16. Diode laser, vitrectomy and intravitreal triamcinolone. A comparative study for the treatment of diffuse non tractional diabetic macular edema.
Parolini B; Panozzo G; Gusson E; Pinackatt S; Bertoldo G; Rottini S; Pignatto S
Semin Ophthalmol; 2004; 19(1-2):1-12. PubMed ID: 15658006
[TBL] [Abstract][Full Text] [Related]
17. Six-month visual outcome after pars plana vitrectomy in proliferative diabetic retinopathy with or without a single preoperative injection of intravitreal bevacizumab.
Gupta A; Bansal R; Gupta V; Dogra MR
Int Ophthalmol; 2012 Apr; 32(2):135-44. PubMed ID: 22450558
[TBL] [Abstract][Full Text] [Related]
18. Predictors of visual outcome after pars plana vitrectomy secondary to proliferative diabetic retinopathy.
Nisic F; Gadzo AP; Fajkic A; Nisic A; Miokovic AP; Damjanovic G; Begic E; Beslic N; Lepara O
Rom J Ophthalmol; 2023; 67(3):283-288. PubMed ID: 37876512
[No Abstract] [Full Text] [Related]
19. Ranibizumab Pretreatment in Vitrectomy with Internal Limiting Membrane Peeling on Diabetic Macular Edema in Severe Proliferative Diabetic Retinopathy.
Guan J; Cai N; Liu LM; Zhao N; Liu NN
Diabetes Ther; 2020 Jun; 11(6):1397-1406. PubMed ID: 32356244
[TBL] [Abstract][Full Text] [Related]
20. A pilot study of viscoelastic agent to prevent recurrent vitreous hemorrhage after vitrectomy for proliferative diabetic retinopathy.
Qiu CY; Shi YY; Zhao HW; Gong YB; Nie C; Wang MG; Jia R; Zhao J; Wang X; Luo L
BMC Ophthalmol; 2022 Dec; 22(1):509. PubMed ID: 36550421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
